DEVELOPMENT OF A NOVEL DRUG-RELEASE SYSTEM, TIME-CONTROLLED EXPLOSION SYSTEM (TES) .2. DESIGN OF MULTIPARTICULATE TES AND IN-VITRO DRUG-RELEASE PROPERTIES

被引:0
|
作者
UEDA, S [1 ]
YAMAGUCHI, H [1 ]
KOTANI, M [1 ]
KIMURA, S [1 ]
TOKUNAGA, Y [1 ]
KAGAYAMA, A [1 ]
HATA, T [1 ]
机构
[1] FUJISAWA PHARMACEUT CO LTD, TECHNOL DEV LABS, YODOGAWA KU, OSAKA 532, JAPAN
关键词
TIME-CONTROLLED EXPLOSION SYSTEM (TES); MULTIPARTICULATE; SWELLING AGENT; SOLUBILITY; DRUG RELEASE; LAG TIME;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For the design of multiparticulate Time-Controlled Explosion System (TES), the thickness of the swelling agent layer was optimized by determining the amount of drug released. Low-substituted hydroxypropylcellulose (L-HPC) was used as a swelling agent. At 120 mu m thickness, tiapride hydrochloride was released before the membrane destruction, while at 180 mu m thickness the drug release was completed within 30 min after the destruction. Similar results were obtained for TES containing metoclopramide hydrochloride. These results suggest that the L-HPC layer must be at least 180 mu m thick. To evaluate the effect of solubility of the drug on release behavior, sodium diclofenac and nilvadipine were used as typical model drugs with an acidic functional group and poor solubility, respectively. The release studies were performed for these drugs in TES with 180 pm L-HPC layer. It is demonstrated that TES can provide a constant drug release profile, regardless of the solubility of a drug and dissolution conditions. In the case that L-HPC layer was fixed at a thickness of 180 mu m, the release of diclofenac was not influenced by drug content.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 50 条
  • [1] DEVELOPMENT OF A NOVEL DRUG-RELEASE SYSTEM, TIME-CONTROLLED EXPLOSION SYSTEM (TES) .1. CONCEPT AND DESIGN
    UEDA, S
    HATA, T
    ASAKURA, S
    YAMAGUCHI, H
    KOTANI, M
    UEDA, Y
    JOURNAL OF DRUG TARGETING, 1994, 2 (01) : 35 - 44
  • [2] DEVELOPMENT OF A NOVEL DRUG-DELIVERY SYSTEM, TIME-CONTROLLED EXPLOSION SYSTEM (TES) .4. IN-VIVO DRUG-RELEASE BEHAVIOR
    UEDA, S
    IBUKI, R
    KAWAMURA, A
    MURATA, S
    TAKAHASHI, T
    KIMURA, S
    HATA, T
    JOURNAL OF DRUG TARGETING, 1994, 2 (02) : 133 - 140
  • [3] DEVELOPMENT OF A NOVEL DRUG-RELEASE SYSTEM, TIME-CONTROLLED EXPLOSION SYSTEM (TES) .3. RELATION BETWEEN LAG TIME AND MEMBRANE THICKNESS
    UEDA, S
    IBUKI, R
    KIMURA, S
    MURATA, S
    TAKAHASHI, T
    TOKUNAGA, Y
    HATA, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1994, 42 (02) : 364 - 367
  • [4] DESIGN AND DEVELOPMENT OF TIME-CONTROLLED EXPLOSION SYSTEM (TES) AS A CONTROLLED RELEASE SYSTEM
    HATA, T
    IBUKI, R
    UEDA, S
    UEDA, Y
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S266 - S266
  • [5] Influence of physiological variables on the in vitro drug-release behavior of a polysaccharide matrix controlled-release system
    Mu, XH
    Tobyn, MJ
    Staniforth, JN
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (01) : 19 - 29
  • [6] DEVELOPMENT OF A NOVEL DRUG-DELIVERY SYSTEM, TIME-CONTROLLED EXPLOSION SYSTEM (TES) .5. ANIMAL PHARMACODYNAMIC STUDY AND HUMAN BIOAVAILABILITY STUDY
    HATA, T
    SHIMAZAKI, Y
    KAGAYAMA, A
    TAMURA, S
    UEDA, S
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 110 (01) : 1 - 7
  • [7] GLIADIN FILMS .1. PREPARATION AND IN-VITRO EVALUATION AS A CARRIER FOR CONTROLLED DRUG-RELEASE
    STELLA, V
    VALLEE, P
    ALBRECHT, P
    POSTAIRE, E
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 121 (01) : 117 - 121
  • [8] APPLICATION OF CURDLAN TO CONTROLLED DRUG-DELIVERY .3. DRUG-RELEASE FROM SUSTAINED-RELEASE SUPPOSITORIES IN-VITRO
    KANKE, M
    TANABE, E
    KATAYAMA, H
    KODA, Y
    YOSHITOMI, H
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1995, 18 (08) : 1154 - 1158
  • [10] Characterization of sodium phenytoin co-gelled with titania for a controlled drug-release system
    Lopez, T.
    Quintana, P.
    Ortiz-Islas, E.
    Vinogradova, E.
    Manjarrez, J.
    Aguilar, D. H.
    Castillo-Ocampo, P.
    Magana, C.
    Azamar, J. A.
    MATERIALS CHARACTERIZATION, 2007, 58 (8-9) : 823 - 828